ArticleInvestigational new drugs2011

Action of SN 28049, a new DNA binding topoisomerase II-directed antitumour drug: comparison with doxorubicin and etoposide.

Catherine J Drummond et al.PubMed ↗Publisher ↗

No numbers read from the abstract.